Fabio Arturo Iannotti Selected Research

Benign Neonatal Epilepsy (Benign Familial Neonatal Convulsions)

1/2011

The Voltage-Sensing Domain of K(v)7.2 Channels as a Molecular Target for Epilepsy-Causing Mutations and Anticonvulsants.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Fabio Arturo Iannotti Research Topics

Disease

5	Schizophrenia (Dementia Praecox) 10/2022 - 01/2019
5	Obesity 12/2021 - 11/2013
5	Epilepsy (Aura) 05/2021 - 01/2010
4	Cognitive Dysfunction 10/2022 - 01/2019
3	Inflammation (Inflammations) 02/2021 - 04/2016
3	Neuralgia (Stump Neuralgia) 02/2021 - 12/2019
3	Hyperalgesia 02/2021 - 01/2018
2	Substance-Related Disorders (Drug Abuse) 05/2021 - 01/2021
2	Neurobehavioral Manifestations 01/2021 - 01/2020
2	Brain Concussion (Cerebral Concussion) 01/2020 - 01/2020
1	Chronic Disease (Chronic Diseases) 02/2021
1	Cytokine Release Syndrome 02/2021
1	Keratitis 02/2021
1	Peripheral Nervous System Diseases (PNS Diseases) 02/2021
1	Mental Disorders (Mental Disorder) 01/2021
1	Peripheral Nerve Injuries 01/2021
1	Overweight 01/2021
1	Chronic Pain 01/2021
1	Tobacco Use Disorder (Nicotine Dependence) 09/2020
1	Anhedonia 09/2020
1	Leukemia 12/2019
1	Pain (Aches) 09/2019
1	Neurodegenerative Diseases (Neurodegenerative Disease) 02/2019
1	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 01/2019
1	Type 2 Diabetes Mellitus (MODY) 01/2019
1	Dyslipidemias (Dyslipidemia) 01/2019
1	Lung Neoplasms (Lung Cancer) 04/2016
1	Vascular Remodeling 04/2016
1	Neoplasms (Cancer) 04/2016
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2016
1	Nervous System Diseases (Neurological Disorders) 01/2016
1	Anorexia 11/2013
1	Body Weight (Weight, Body) 11/2013
1	Benign Neonatal Epilepsy (Benign Familial Neonatal Convulsions) 01/2011

Drug/Important Bio-Agent (IBA)

8	EndocannabinoidsIBA 10/2022 - 01/2016
6	CannabidiolIBA 05/2021 - 01/2019
4	LipidsIBA 01/2021 - 01/2016
3	Methylazoxymethanol AcetateIBA 10/2022 - 01/2019
3	Dopamine (Intropin)FDA LinkGeneric 01/2021 - 01/2020
3	CannabinoidsIBA 01/2021 - 11/2013
2	AM 251 (AM251)IBA 10/2022 - 01/2019
2	Antimitotic AgentsIBA 10/2022 - 01/2019
2	OrexinsIBA 10/2021 - 01/2021
2	Messenger RNA (mRNA)IBA 01/2021 - 01/2020
2	2-pentadecyl-2-oxazolineIBA 01/2021 - 01/2020
2	Potassium Channels (Potassium Channel)IBA 09/2019 - 01/2010
2	Anticonvulsants (Antiepileptic Drugs)IBA 01/2011 - 01/2010
1	LeptinIBA 12/2021
1	Rosiglitazone (Avandia)FDA Link 12/2021
1	noladin etherIBA 12/2021
1	Glucosamine (Dona)IBA 02/2021
1	GlycolipidsIBA 02/2021
1	NF-kappa B (NF-kB)IBA 02/2021
1	Toll-Like Receptors (Toll-Like Receptor)IBA 02/2021
1	CytokinesIBA 02/2021
1	Lipid AIBA 02/2021
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 02/2021
1	MonosaccharidesIBA 02/2021
1	Prostaglandins AIBA 02/2021
1	Formaldehyde (Formol)FDA Link 02/2021
1	Glutamic Acid (Glutamate)FDA Link 01/2021
1	Orexin ReceptorsIBA 01/2021
1	gamma-Aminobutyric Acid (GABA)IBA 01/2021
1	Histamine H3 Receptors (Histamine H3 Receptor)IBA 01/2021
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2021
1	LigandsIBA 01/2021
1	Histamine (Histamine Dihydrochloride)FDA Link 01/2021
1	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2021
1	Morphine (MS Contin)FDA LinkGeneric 09/2020
1	anandamide (arachidonylethanolamide)IBA 09/2020
1	Alanine (L-Alanine)FDA Link 09/2020
1	AmidesIBA 09/2020
1	Fatty Acids (Saturated Fatty Acids)IBA 09/2020
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 09/2020
1	Naloxone (Narcan)FDA LinkGeneric 09/2020
1	SaccharinIBA 09/2020
1	N-oleoylglycineIBA 01/2020
1	Antipsychotic Agents (Antipsychotics)IBA 01/2020
1	Dopamine D3 ReceptorsIBA 01/2020
1	Substance PIBA 12/2019
1	palmidrolIBA 12/2019
1	Capsaicin (Zostrix)FDA Link 09/2019
1	BradykininIBA 09/2019
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 02/2019
1	DystrophinIBA 01/2019
1	Haloperidol (Haldol)FDA LinkGeneric 01/2019
1	Polychlorinated Biphenyls (PCBs)IBA 01/2019
1	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 01/2019
1	cannabidivarinIBA 01/2019
1	Inflammation MediatorsIBA 01/2018
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 04/2016
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2016
1	Glucose (Dextrose)FDA LinkGeneric 01/2016
1	Transient Receptor Potential ChannelsIBA 11/2014
1	RimonabantIBA 11/2013
1	Pharmaceutical PreparationsIBA 01/2010
1	ezogabine (retigabine)IBA 01/2010

Therapy/Procedure

2	Therapeutics 09/2019 - 01/2010
1	Fecal Microbiota Transplantation 12/2021
1	Aftercare (After-Treatment) 01/2019